Documents / Official release
This Defense Intelligence Reference Document, dated 31 March 2010 and numbered DIA-08-1003-020, was prepared by the Defense Intelligence Agency's Defense Warning Office under its Advanced Aerospace Weapon System Applications Program. It surveys biosensors and biomedical microelectromechanical systems, covering brain-implanted micromachine neuroelectrodes, drug-delivery pumps, glucose sensors, neural interfaces, retinal prostheses, microfluidic lab chips, NASA cell-culture systems and microcantilever sensors. It concludes that the field is expanding rapidly, with nanomechanical systems expected to follow.
From the source: Release of 2026-09-18 Incident: 3/31/10, Las Vegas, Nevada. Released with redactions. This document is a Defense Intelligence Reference Document (DIRD), a technical reference format used by the Defense Intelligence Agency (DIA) to capture baseline knowledge on a specific topic for later analytic use. DIRDs are best understood as reference and synthesis products rather than as original research. It is one of 38 DIRDs produced under the Advanced Aerospace Weapon System Applications Program (AAWSAP) between 2009 and 2011. Because AAWSAP’s scope permitted a broad range of supporting topics, not every DIRD in the series directly concerns aerospace systems or future threat assessment. The following summary reflects the DIRD’s scope and framing at the time of writing and should not be read as implying current validation of the concepts discussed. This DIRD surveys biosensors and BioMEMS, a broad class of miniature biomedical devices that combine microscale engineering with sensing, fluid handling, stimulation, or drug-delivery functions. The report reviews major application areas including implantable blood-chemistry sensors, neural interfaces, neurostimulation, drug-delivery pumps, microfluidic systems, and emerging nanoscale extensions of the field, while emphasizing that miniaturization can improve sensitivity and enable functions that are difficult or impossible at larger scales. However, it also makes clear that practical development is constrained by biocompatibility, long-term stability, sensor drift, device degradation inside the body, and the high regulatory burden associated with implantable medical systems. The document presents BioMEMS as a rapidly growing and productive field whose future advances are likely to come through continued improvements in fabrication, materials, and reliability.
UNCLASSIFIED/ /P'OR: OP'P'l@IAL WS& 0Nk¥
Varieties of BioMEMs and Sensors
--- ---·
·-•· ---
. I . . I .
---· ---· ---·
Figure 1. Varietie.s of BioMEMS and Sensors. These BioMEMS devices were made at Arizona State University
(ASU). They represent many of the areas of BioMEMS research .
CHARACTERISTICS OF BIOMEMS
Conceiving and designing BioMEMS devices requires a different perspective of the
physical world. These devices can operate on principles such as capillary force, van der
Waals forces, and electric-field forces. These forces become relatively strong when the
size scale reaches very small dimensions. In the realm of the very small, the force of
gravity is far less important than electrical charge and viscosity.
From the perspective of microscale devices, engineers need to think about
accomplishing tasks on an extremely subtle scale but with an exceptionally effective
result. BioMEMS employs engineering sciences in ways that are more than just scaling
down familiar devices used in biomedical applications. Rather, employment of new
structures and new materials including polymers and biological components is
necessary. In addition we need to be concerned about things like biocompatibility (the
effect of the device on body tissue) as well as the degradation effects of tissues and
body fluids on the device itself.
Development of a new product that is targeted for implantation into the human body is
particularly expensive due to federal regulation of medical devices. Devices must be
shown to be effective for their intended use, and above all devices must be proved safe.
Bringing a new device to market is not unlike the development of a new drug. In order
UNCLASSIFIED/ {FOR OFFICIO! !PEii QDlk¥
2 Not linked to a story yet.
Official release, from the pursue collection. The PDF is mirrored here; the original link is above. 45 pages are in the text index: search them above, or from the library's search.